Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute discusses molecular testing in determining treatment approach for patients with colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
Molecular Tests for Treatment in CRC Patients
